Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Atkinson

Showing results (271-280 of 374) with videos related to

Pageof 38
Sort By:
Diabetes|December 13, 2019
Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes DiagnosisMelanie R Shapiro, Clive H Wasserfall, Sean M McGrail, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 2007
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain geneMarie King, Todd Pearson, Leonard D Shultz, et al.
Cell|February 5, 2021
TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetesAlberto Sada Japp, Wenzhao Meng, Aaron M Rosenfeld, et al.
Diabetes|July 25, 2009
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic miceMatthew J Parker, Song Xue, John J Alexander, et al.
Diabetes|December 7, 2016
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune DiabetesAaron W Michels, Laurie G Landry, Kristen A McDaniel, et al.
The Journal of Clinical Investigation|April 10, 2012
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in miceTatiana Takiishi, Hannelie Korf, Tom L Van Belle, et al.
Diabetes Care|August 7, 2021
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet CohortsMichael G Voss, David D Cuthbertson, Mario M Cleves, et al.
Diabetes|January 1, 2016
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD MiceRonald G Gill, Philippe P Pagni, Tinalyn Kupfer, et al.
Diabetes Care|March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 25, 2013
Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetesMichael J Haller, Clive H Wasserfall, Maigan A Hulme, et al.
Pageof 38

Showing results (271-280 of 374) with videos related to

Sort By:
Pageof 38
Diabetes|December 13, 2019
Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes DiagnosisMelanie R Shapiro, Clive H Wasserfall, Sean M McGrail, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 2007
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain geneMarie King, Todd Pearson, Leonard D Shultz, et al.
Cell|February 5, 2021
TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetesAlberto Sada Japp, Wenzhao Meng, Aaron M Rosenfeld, et al.
Diabetes|July 25, 2009
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic miceMatthew J Parker, Song Xue, John J Alexander, et al.
Diabetes|December 7, 2016
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune DiabetesAaron W Michels, Laurie G Landry, Kristen A McDaniel, et al.
The Journal of Clinical Investigation|April 10, 2012
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in miceTatiana Takiishi, Hannelie Korf, Tom L Van Belle, et al.
Diabetes Care|August 7, 2021
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet CohortsMichael G Voss, David D Cuthbertson, Mario M Cleves, et al.
Diabetes|January 1, 2016
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD MiceRonald G Gill, Philippe P Pagni, Tinalyn Kupfer, et al.
Diabetes Care|March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 25, 2013
Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetesMichael J Haller, Clive H Wasserfall, Maigan A Hulme, et al.
Pageof 38